Literature DB >> 33473179

The Met1-linked ubiquitin machinery in inflammation and infection.

Berthe Katrine Fiil1, Mads Gyrd-Hansen2,3.   

Abstract

Ubiquitination is an essential post-translational modification that regulates most cellular processes. The assembly of ubiquitin into polymeric chains by E3 ubiquitin ligases underlies the pleiotropic functions ubiquitin chains regulate. Ubiquitin chains assembled via the N-terminal methionine, termed Met1-linked ubiquitin chains or linear ubiquitin chains, have emerged as essential signalling scaffolds that regulate pro-inflammatory responses, anti-viral interferon responses, cell death and xenophagy of bacterial pathogens downstream of innate immune receptors. Met1-linked ubiquitin chains are exclusively assembled by the linear ubiquitin chain assembly complex, LUBAC, and are disassembled by the deubiquitinases OTULIN and CYLD. Genetic defects that perturb the regulation of Met1-linked ubiquitin chains causes severe immune-related disorders, illustrating their potent signalling capacity. Here, we review the current knowledge about the cellular machinery that conjugates, recognises, and disassembles Met1-linked ubiquitin chains, and discuss the function of this unique posttranslational modification in regulating inflammation, cell death and immunity to pathogens.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33473179      PMCID: PMC7816137          DOI: 10.1038/s41418-020-00702-x

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  102 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Ubiquitination in disease pathogenesis and treatment.

Authors:  Doris Popovic; Domagoj Vucic; Ivan Dikic
Journal:  Nat Med       Date:  2014-11-06       Impact factor: 53.440

Review 3.  Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.

Authors:  Rune B Damgaard; Mads Gyrd-Hansen
Journal:  Discov Med       Date:  2011-03       Impact factor: 2.970

Review 4.  The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation.

Authors:  Matous Hrdinka; Mads Gyrd-Hansen
Journal:  Mol Cell       Date:  2017-10-19       Impact factor: 17.970

5.  Systematic and quantitative assessment of the ubiquitin-modified proteome.

Authors:  Woong Kim; Eric J Bennett; Edward L Huttlin; Ailan Guo; Jing Li; Anthony Possemato; Mathew E Sowa; Ramin Rad; John Rush; Michael J Comb; J Wade Harper; Steven P Gygi
Journal:  Mol Cell       Date:  2011-09-08       Impact factor: 17.970

Review 6.  The ubiquitin code.

Authors:  David Komander; Michael Rape
Journal:  Annu Rev Biochem       Date:  2012-04-10       Impact factor: 23.643

Review 7.  NOD-like receptors: role in innate immunity and inflammatory disease.

Authors:  Grace Chen; Michael H Shaw; Yun-Gi Kim; Gabriel Nuñez
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 8.  Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages.

Authors:  Yogesh Kulathu; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2012-07-23       Impact factor: 94.444

9.  OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.

Authors:  Kirstin Keusekotten; Paul Ronald Elliott; Laura Glockner; Berthe Katrine Fiil; Rune Busk Damgaard; Yogesh Kulathu; Tobias Wauer; Manuela Kathrin Hospenthal; Mads Gyrd-Hansen; Daniel Krappmann; Kay Hofmann; David Komander
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

10.  LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.

Authors:  Peter Draber; Sebastian Kupka; Matthias Reichert; Helena Draberova; Elodie Lafont; Diego de Miguel; Lisanne Spilgies; Silvia Surinova; Lucia Taraborrelli; Torsten Hartwig; Eva Rieser; Luigi Martino; Katrin Rittinger; Henning Walczak
Journal:  Cell Rep       Date:  2015-12-06       Impact factor: 9.423

View more
  8 in total

1.  HOIL1 regulates group 2 innate lymphoid cell numbers and type 2 inflammation in the small intestine.

Authors:  Matthew J Wood; Jeffrey N Marshall; Victoria L Hartley; Ta-Chiang Liu; Kazuhiro Iwai; Thaddeus S Stappenbeck; Donna A MacDuff
Journal:  Mucosal Immunol       Date:  2022-05-09       Impact factor: 8.701

2.  Linear ubiquitin chains break blood vessel branches.

Authors:  Yuri Shibata; David Komander
Journal:  Cell Res       Date:  2021-10       Impact factor: 46.297

Review 3.  TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.

Authors:  Ling Wang; Shunbin Ning
Journal:  Viruses       Date:  2021-02-11       Impact factor: 5.818

4.  GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation.

Authors:  Qianjin Liu; Tianle Gu; Ling-Yan Su; Lijin Jiao; Xinhua Qiao; Min Xu; Ting Xie; Lu-Xiu Yang; Dandan Yu; Ling Xu; Chang Chen; Yong-Gang Yao
Journal:  Redox Biol       Date:  2021-10-18       Impact factor: 11.799

Review 5.  The ubiquitin ligation machinery in the defense against bacterial pathogens.

Authors:  Ishita Tripathi-Giesgen; Christian Behrends; Arno F Alpi
Journal:  EMBO Rep       Date:  2021-09-13       Impact factor: 8.807

Review 6.  Biochemistry, Pathophysiology, and Regulation of Linear Ubiquitination: Intricate Regulation by Coordinated Functions of the Associated Ligase and Deubiquitinase.

Authors:  Yasuhiro Fuseya; Kazuhiro Iwai
Journal:  Cells       Date:  2021-10-09       Impact factor: 6.600

Review 7.  The RING finger protein family in health and disease.

Authors:  Chunmei Cai; Yan-Dong Tang; Jingbo Zhai; Chunfu Zheng
Journal:  Signal Transduct Target Ther       Date:  2022-08-30

Review 8.  The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Authors:  Min Zou; Qi-Shan Zeng; Jiao Nie; Jia-Hui Yang; Zhen-Yi Luo; Hua-Tian Gan
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.